The market opened in the green on April 29, 2020. The previous trading session witnessed the Sensex going up by 1.2 percent to end at 32,114 and the Nifty was up 1.1 percent to close at 9,380.

Gujarat-based pharma company, Hester Biosciences Limited announced on Wednesday that it is joining hands with Indian Institute of Technology, Guwahati to work on the vaccine development against COVID-19. The agreement between the two parties was signed on April 15, 2020.

The market opened in the green on April 29, 2020. The previous trading session witnessed the Sensex going up by 1.2 percent to end at 32,114 and the Nifty was up 1.1 percent to close at 9,380.

The market opened in the green on April 29, 2020, overall volumes in futures & options currently stand at 1.71 crore contracts with a turnover of Rs. 9,04,461.82 crore.

The market opened in the green on April 29, 2020, overall volumes in futures & options currently stand at 1.71 crore contracts with a turnover of Rs. 9,04,461.82 crore.

The stock of organic chemicals manufacturer & supplier, IOL Chemicals & Pharmaceuticals Ltd, witnessed a jump today on being recognised as ‘three star export house’ by Ministry of Commerce & Industry, Government of India. 

Glenmark Pharmaceuticals announced on Wednesday that it had been granted tentative approval by United States Food & Drug Administration (USFDA) for Dapagliflozin and Saxagliptin tablets, 10 mg/5 mg, the generic version of Qtern 1 tablets, 10 mg/5 mg of AstraZeneca AB.

Moody’s Investors Service on Tuesday slashed India growth forecast for 2020 to 0.2 per cent. 

Strides Pharma Science Limited has developed and commercialised Favipiravir antiviral tablets which is the generic version of Avigan of Toyama Chemical (Japan). It is the first Indian company to develop and commercially launch Favipiravir tablets for the global markets.

The company has expanded its portfolio with this after a successful launch in USA. This is Biocon’s second launch in Canada with Mylan.